Home Page >> Potential Lawsuit >> Atlantic Power Corporation Atlantic Power Corporation AT 401(k) / ERISA Lawsuit Atlantic Power Corporation has been accused of securities fraud. If you are a current or former employee or are a member of any of Atlantic Power Corporation investment plans or profit sharing retirement plans you may be included in this possible Atlantic Power Corporation 401(k) or Employee Retirement Income Security Act (ERISA) class action. If you purchased or held Atlantic Power Corporation stock in one of those plans during the periods Jul-23-10 to Mar-4-13, you may have a claim. Under ERISA, Atlantic Power Corporation employees can file a lawsuit against the company for putting stock options at risk. Atlantic Power Corporation employees have a claim if they can prove their employer violated its fiduciary duty to its employees. Fiduciary duty refers to a company's responsibility to the people who invest in it. If an employer puts the company's interest ahead of the investors', it has broken its fiduciary duty. A fiduciary is a person that exercises discretion over the management of plan assets or exercises discretionary control over the administration of the plan. ERISA is a federal law that sets minimum standards for pension and health plans set up by private businesses. ERISA was designed to protect people who participate in employee benefit plans, including employees with stock options in a company. Stock options are a form of compensation in which employees are given the opportunity to purchase shares of the company stock at a certain price. Atlantic Power Corporation 401(k) / ERISA Legal Help If you have suffered from Atlantic Power Corporation 401(k) plan losses, you may qualify for damages or remedies that may be awarded in a possible Atlantic Power Corporation ERISA class action lawsuit. Please click the link below to submit your complaint and we will have a lawyer review your ERISA complaint.If you are NOT a current or former employee of this company, please use this form to register your complaint. Thank you. <br>For the original version including any supplementary images or video, visit http://www.lawyersandsettlements.com/case/atlantic-power-corporation-at-securities-erisa.html?ref=rss
What are you looking for? Home Page >> Settlements >> Drywaller Awarded $26.6M in Asbestos Mesothelioma Lawsuit Drywaller Awarded $26.6M in Asbestos Mesothelioma Lawsuit Please click here for a free evaluation of your claim San Pedro, CA: An asbestos mesothelioma verdict was reached in March in the case of Michael Sutherland, a former drywaller diagnosed with mesothelioma, a cancer caused by asbestos. The Los Angeles Superior Court jury that heard the case returned its verdict awarding $26.6 million to Michael and his wife Suszi. Mike testified that he worked as a drywaller in northern San Diego County from 1967, while he was still attending Madison High School, through 1993?with frequent breaks for extended surfing trips to Hawaii and Mexico. He worked at countless residential and commercial jobsites during the construction ?boom? that occurred in north county in the 1970s, the same time that cancer-causing asbestos was used in many construction products including joint compound, fire-rated drywall, caulk, stucco, roofing mastic and asbestos cement pipe. ?With all the trades working on top of each other trying to finish one job and move on to the next, it was always dusty,? Mike recalled, ?It wasn?t until I became a lead maintenance mechanic at UC San Diego and attended a class on job safety in 2003 that I learned that so many of the materials used on the jobs back then contained asbestos.? The Sutherlands? case (LASC case # BC486980) was filed on June 20, 2012. Over 30 defendants were named in the case. Settlements were reached with a number of defendants prior to trial. Stucco manufacturer, Highland Stucco and Lime Products, Inc., the sole remaining defendant at trial, argued that other companies and even Mr. Sutherland himself were responsible for his exposure to asbestos. But the jury ultimately assessed blame on Highland for its role in subjecting Mr. Sutherland and other members of the public to its dangerous products. ?I was surprised to learn at trial just how much asbestos was in stucco,? Mike stated, ?even though I rarely worked hands-on with the stuff, I was exposed to dust when the bags were dumped into large mixers and when we had to scrape off areas of over-spray that came into the homes through windows and doors.? Mike is grateful for the jury?s award and for the hard work of his legal team, but would gladly trade it for the return of his health. Prior to his diagnosis in May 2012, Mike enjoyed his job at UCSD and had no plans of retiring. He also continued to indulge his life-long passion for surfing, hitting the waves on the iconic surf breaks of north county San Diego two or more times a week. Legal Help If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below. <br>For the original version including any supplementary images or video, visit http://www.lawyersandsettlements.com/settlements/17274/drywaller-awarded-26-6m-in-asbestos-mesothelioma.html?ref=rss
Home Page >> Potential Lawsuit >> Amiodarone Increases Risk for Cancer Study Finds Amiodarone Increases Risk for Cancer Study Finds Washington, DC: Men taking the http://184.108.40.206/~acc237/los-angeles-medical-malpractice-lawyer-com/62-report-details-demise-of-class-actions-3 antiarrhythmia drug amiodarone (Nexterone, Baxter Healthcare Corp), are at increased risk for cancer, according to a study published online in Cancer. The study also showed that men who had been exposed to the drug extensively, were at particularly high risk. The retrospective study found that the risk for cancer increased by nearly 20% in men taking amiodarone, compared with the general population, authors Chia-Jen Liu, MD, of National Yang-Ming University Hospital in Yilan, Taiwan and colleagues reported. Further, that risk increased to 46% among men whose cumulative defined daily doses in a year exceeded 180. The antiarrhythmia drug has been linked to numerous adverse health effects including thyroid dysfunction, pulmonary fibrosis, and skin and thyroid malignancies. The results from this latest study add to those of an earlier meta-analysis which also showed a potential association between amiodarone and cancer. Although amiodarone was approved in Europe and Canada and was commonly used in the 1980s, the FDA was reluctant to officially approve the use of amiodarone, since initial reports had shown increased incidence of serious pulmonary side effects of the drug. The FDA recognized that it was a dangerous drug and told doctors to be careful about its use. Legal Help If you or a loved one has suffered similar damages or injuries, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation. <br>For the original version including any supplementary images or video, visit http://www.lawyersandsettlements.com/case/cordarone-side-effects-amiodarone-cancer.html?ref=rss
What are you looking for? Home Page http://220.127.116.11/~acc237/los-angeles-medical-malpractice-lawyer-com/106-report-details-demise-of-class-actions-12 >> Potential Lawsuit >> Deaths Prompt FDA to Pull DMAA-Containing Supplements From the Market Deaths Prompt FDA to Pull DMAA-Containing Supplements From the Market Please click here for a free evaluation of your DMAA-Containing Supplements claim Washington, DC: The Food and Drug Administration (FDA) has issued a statement concerning supplements that contain the stimulant dimethylamylamine (DMAA), notifying consumers that it is using "all available tools at its disposal" to eliminate DMAA-containing supplements from the market. As of April 11, 2013, FDA had received 86 reports of illnesses and death associated with supplements containing DMAA. The illnesses reported include heart problems and nervous system or psychiatric disorders. DMAA is most commonly used in supplements promising weight loss, muscle building and performance enhancement; it can elevate blood pressure and could lead to cardiovascular problems, including heart attack, shortness of breath and tightening of the chest. Given the known biological activity of DMAA, the ingredient may be particularly dangerous when used with caffeine. Some examples of products containing include OxyElite Pro and Jack3d. The FDA has warned companies known to be using DMAA in dietary supplements that those products containing this ingredient are illegal. Such warnings offer the quickest way at the FDA's disposal to halt the further distribution of dietary supplements containing DMAA in the marketplace. In fact, all but one of the companies sent a Warning Letter have agreed to stop using DMAA as an ingredient in their dietary supplements. The one company that has yet to agree to such action, USPLabs, has responded to the FDA's warning by submitting published studies that purport to challenge the FDA's conclusions. However, after reviewing the studies provided by USPLabs, the FDA has found [source] the information insufficient to defend the use of DMAA as an ingredient in dietary supplements. The FDA is advising that consumers look for DMAA listed on the product label. Other names that refer to DMAA are: 1,3-DMAA <br>For the original version including any supplementary images or video, visit http://www.lawyersandsettlements.com/case/dmaa-dietary-supplements-oxyelite-pro-jack3d-fda.html?ref=rss
Home Page >> Potential Lawsuit >> Victoza Side Effects - Pancreatic and Thyroid Cancer Victoza Side Effects Were you looking for Byetta or Diabetes Medication Lawsuits or Januvia lawsuits?
In March 2013 the US Food and Drug Administration (FDA) announced results of a study suggesting Victoza side effects could include an increased risk of Victoza pancreatitis. Victoza has already reportedly been linked in animal studies to an increased risk of a rare thyroid cancer, according to the FDA. So far, no Victoza lawsuits have been filed, although other drugs in the same medication class are the subject of lawsuits. FREE CASE EVALUATION Send your Victoza Cancer claim to a Lawyer who will review your claim at NO COST or obligation. Victoza Pancreatic Cancer On March 14, 2013, the FDA issued a Drug Safety Communication, alerting the public to a study that suggested Victoza and other type 2 diabetes medications were linked to an increased risk of pancreatitis and pre-cancerous cellular changes, called pancreatic duct metaplasia. These risks were reportedly found in a group of drugs known as incretin mimetics, which includes Byetta, Bydureon, Victoza, Januvia and other medications. At the time, the FDA said it was not changing the safety warnings of the drugs, but that it was reviewing data from the study, including requesting the methodology used so the agency could investigate the risk of pancreatic toxicity. Other drugs in the incretin mimetic class have been linked to an increased risk of acute pancreatitis, including fatal and nonfatal instances of the condition. http://attorney-in-palm-desert.com/more-information/personal-injury/ When Victoza was approved, the FDA noted that in five clinical trials of Victoza, there were seven cases of pancreatitis in patients using Victoza, compared with one case of pancreatitis in a patient who used a different diabetes medicine. Victoza Thyroid Cancer On April 19, 2012, the public advocacy group Public Citizen filed a petition with the FDA requesting the agency remove Victoza from the market. Public Citizen cited the risk of thyroid cancer, pancreatitis, http://18.104.22.168/~acc237/los-angeles-medical-malpractice-lawyer-com/60-biggest-california-verdicts-continue-to-go-to-corporate-plaintiffs-3 serious allergic reactions and kidney failure as outweighing any possible benefits to the drug. In a news release, Public Citizen noted that two FDA pharmacologists and an FDA clinical safety reviewer advised against approving Victoza. Victoza, known generically as liraglutide, is used to treat type 2 diabetes and is made by Novo Nordisk. It was approved by the FDA in 2010 to treat bype 2 diabetes. When Victoza was approved, the FDA noted that animal data suggested a rare type of thyroid cancer, known as medullary thyroid cancer, was linked to the use of Victoza. According to the FDA, studies in mice and rats showed liraglutide was linked to the development of tumors in the thyroid gland, "especially at doses that were 8-times higher than what humans would receive." As a result, the FDA requested a Risk Evaluation and Mitigation Strategy for Victoza and further required a five-year epidemiological study of Victoza. Victoza Cancer Legal Help If you or a loved one has suffered damages or injuries from Victoza, please click the link below and your complaint will be sent to a Drug/Medical Device lawyer who may evaluate your claim at no cost or obligation. <br>For the original version including any supplementary images or video, visit http://www.lawyersandsettlements.com/case/victoza-cancer.html?ref=rss